Antibody responses of healthy infants to concurrent administration of a bivalent Haemophilus influenzae type b hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines
Dj. West et al., Antibody responses of healthy infants to concurrent administration of a bivalent Haemophilus influenzae type b hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines, BIODRUGS, 15(6), 2001, pp. 413-418
Objective: To confirm that children given a bivalent Haemophilus influenzae
type b-hepatitis B vaccine (bivalent Hib-HB vaccine; COMVAX (TM)) concurre
ntly with priming doses of diphtheria-tetanus-pertussis vaccine (DTP), a bo
oster dose of diphtheria-tetanus-acellular pertussis vaccine (DTaP), inacti
vated or oral polio vaccine (IPV or OPV) and measles-mumps-rubella vaccine
(M-M-(RII)-I-(R)) have satisfactory antibody responses to all antigens.
Design: 126 healthy 2-month-old infants were scheduled to receive bivalent
Hib-HB vaccine concurrently with DTP (2 and 4 months of age), OPV or IPV (r
andom allocation to OPV or IPV at 2 months of age; OPV at 4 and 14 to 15 mo
nths of age), DTaP and M-M-(RII)-I-(R) (14 to 15 months of age). A response
was judged, 'adequate' if the lower bound of the 95% confidence interval o
n the proportion of vaccinees having a critical antibody level was < 10 per
centage points below prediction.
Results: Antibodies to hepatitis B virus surface antigen, H. influenzae pol
ysaccharide, diphtheria toxin, tetanus toxin, pertussis agglutinogens, pert
ussis toxin (as measured by enzyme immunoassay but not by Chinese hamster o
vary cell assay), pertussis filamentous haemagglutinin after a booster dose
of DTaP, poliovirus type 2, measles virus, and mumps virus all equalled or
exceeded expected levels. Antibodies to rubella virus and pertussis filame
ntous haemagglutinin (after priming doses of DTP) fell slightly, and in the
case of rubella significantly, below predicted levels. Antibodies to polio
virus types 1 and 3 were also below expectation after 2 doses of polio vacc
ine but were adequate following a third dose of vaccine.
Conclusion: Concurrent administration of bivalent Hib-HB vaccine with primi
ng doses of DTP, a booster dose of DTaP, OPV, IPV, or M-M-(RII)-I-(R) was w
ell tolerated and, with the possible exception of rubella, did not substant
ially impair the antibody response to any antigen.